还原性谷胱甘肽含量在整个发育过程中逐渐增加。
Reduced glutathione (GSH) contents gradually increased during development of embryos.
目的：观察还原性谷胱甘肽治疗酒精性肝病的疗效。
Objective: To observe the efficacy of Glutathlone on the treatment of alcoholic liver diseases.
脱水胚的抗坏血酸和还原性谷胱甘肽含量明显低于对照胚。
Contents of AsA and GSH of dehydrated embryos obviously decreased compared with non-dehydrated embryos.
治疗组在对照组的基础上加用还原性谷胱甘肽静脉点滴，疗程为1个月。
Treatment group: besides above treatment, intravenous drip reduced glutathione was added for 1 month.
保护性物质还原性抗坏血酸（ASA）含量上升，还原性谷胱甘肽（GSH）含量先下降后上升；
The contents of ascorbic acid (ASA) increased, the contents of glutathione (GSH) increased after slightly decreased.
保护性物质还原性抗坏血酸（ASA）含量上升，还原性谷胱甘肽（GSH）含量先下降后上升；
The contents of ascorbic acid (ASA) increased, the contents of glutathione (GSH) increased after slightly decreased.
应用推荐